Huestis MA - Search Results

1

Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.

Abraham TT, Barnes AJ, Lowe RH, Kolbrich Spargo EA, Milman G, Pirnay SO, Gorelick DA, Goodwin RS, Huestis MA. Abraham TT, et al. Among authors: huestis ma. J Anal Toxicol. 2009 Oct;33(8):439-46. doi: 10.1093/jat/33.8.439. J Anal Toxicol. 2009. PMID: 19874650 Free PMC article.

2

Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.

Huestis MA, Henningfield JE, Cone EJ. Huestis MA, et al. J Anal Toxicol. 1992 Sep-Oct;16(5):276-82. doi: 10.1093/jat/16.5.276. J Anal Toxicol. 1992. PMID: 1338215 Clinical Trial.

3

Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH).

Huestis MA, Henningfield JE, Cone EJ. Huestis MA, et al. J Anal Toxicol. 1992 Sep-Oct;16(5):283-90. doi: 10.1093/jat/16.5.283. J Anal Toxicol. 1992. PMID: 1338216

4

Validity testing of the accuPINCH THC test.

Jenkins AJ, Darwin WD, Huestis MA, Cone EJ, Mitchell JM. Jenkins AJ, et al. Among authors: huestis ma. J Anal Toxicol. 1995 Jan-Feb;19(1):5-12. doi: 10.1093/jat/19.1.5. J Anal Toxicol. 1995. PMID: 7723303 Clinical Trial.

5

Validity testing of the EZ-SCREEN cannabinoid test.

Jenkins AJ, Mills LC, Darwin WD, Huestis MA, Cone EJ, Mitchell JM. Jenkins AJ, et al. Among authors: huestis ma. J Anal Toxicol. 1993 Sep;17(5):292-8. doi: 10.1093/jat/17.5.292. J Anal Toxicol. 1993. PMID: 8107464

6

Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.

Huestis MA, Mitchell JM, Cone EJ. Huestis MA, et al. J Anal Toxicol. 1996 Oct;20(6):441-52. doi: 10.1093/jat/20.6.441. J Anal Toxicol. 1996. PMID: 8889681 Clinical Trial.

7

Detection times of marijuana metabolites in urine by immunoassay and GC-MS.

Huestis MA, Mitchell JM, Cone EJ. Huestis MA, et al. J Anal Toxicol. 1995 Oct;19(6):443-9. doi: 10.1093/jat/19.6.443. J Anal Toxicol. 1995. PMID: 8926739 Clinical Trial.

8

Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans.

Huestis MA, Cone EJ. Huestis MA, et al. Ther Drug Monit. 1998 Oct;20(5):570-6. doi: 10.1097/00007691-199810000-00021. Ther Drug Monit. 1998. PMID: 9780137 Clinical Trial.

9

Differentiating new marijuana use from residual drug excretion in occasional marijuana users.

Huestis MA, Cone EJ. Huestis MA, et al. J Anal Toxicol. 1998 Oct;22(6):445-54. doi: 10.1093/jat/22.6.445. J Anal Toxicol. 1998. PMID: 9788519 Clinical Trial.

10

Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing.

Preston KL, Huestis MA, Wong CJ, Umbricht A, Goldberger BA, Cone EJ. Preston KL, et al. Among authors: huestis ma. J Anal Toxicol. 1999 Sep;23(5):313-22. doi: 10.1093/jat/23.5.313. J Anal Toxicol. 1999. PMID: 10488917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

537 results

Search Page

Filters